Pacira BioSciences, Inc.
NASDAQ: PCRX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Frank D. Lee
- Employees
- 788
- Headquarters
- Tampa, United States
- IPO year
- 2011
- Market cap
- $942.5M
- Website
- https://www.pacira.com
Loading PCRX…
Loading profile data…Frequently asked questions about PCRX
What does Pacira BioSciences, Inc. (PCRX) do?
Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health. Its offerings include EXPAREL, an injectable liposomal bupivacaine suspension, and ZILRETTA, an extended-release injectable suspension of triamci...
Where does PCRX trade?
Pacira BioSciences, Inc. (PCRX) trades on the NASDAQ Global Select.
What sector is PCRX in?
Pacira BioSciences, Inc. (PCRX) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Pacira BioSciences, Inc.?
Frank D. Lee is the chief executive officer of Pacira BioSciences, Inc. (PCRX).
Where is Pacira BioSciences, Inc. headquartered?
Pacira BioSciences, Inc. is headquartered in United States.
Does PCRX pay a dividend?
Pacira BioSciences, Inc. (PCRX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PCRX go public?
Pacira BioSciences, Inc. (PCRX) completed its initial public offering in 2011.